Julie Gelderloos, PhD writes for companies around the globe to develop regulatory submissions based on clinical research.
Julie Gelderloos, PhD writes for companies around the globe to develop regulatory submissions based on clinical research.
After obtaining her PhD and conducting scientific research in the field of cellular signal transduction, Dr. Gelderloos merged her writing and communication skills with her scientific
and analytical abilities. As a medical writer for 5 years at Allergan, Inc. and Allos Therapeutics, Inc. she gained valuable clinical and regulatory writing
After obtaining her PhD and conducting scientific research in the field of cellular signal transduction, Dr. Gelderloos merged her writing and communication skills with her scientific
and analytical abilities. As a medical writer for 5 years at Allergan, Inc. and Allos Therapeutics, Inc. she gained valuable clinical and regulatory writing experience within the pharmaceutical/
medical device industries.
Now with 20+ years experience, Dr. Gelderloos works with teams of clinical researchers and statisticians on a wide variety of drugs, biologics, and devices.
PhD, Cellular and Developmental Biology
State University of New York, Stony Brook, NY
BS, Biology
Hope College, Holland, MI
Postdoctoral Research:
National Jewish Center for Medicine, Denver, CO
University of Colorado, Boulder, CO